Historical record - last NADAC effective date: 5/22/2024
Product Information
SPIRONOLACTONE 25 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.0452 per EA under NDC 65162051111. Its NADAC has been published 551 times since Nov 28, 2013.
FDA first approved this application on Jul 2, 2010. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
25 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162051111
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
5/22/2024
Active Ingredients
SPIRONOLACTONEApproval Type
Generic (ANDA)
FDA Application
ANDA091426FDA Approved
7/2/2010
TE Code
AB
On Market Since
8/2/2010
Pharmacological Classes
Price Statistics
The NADAC for SPIRONOLACTONE 25 MG TABLET has been published 551 times since Nov 28, 2013, and over the history we have for it it has declined 42.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0452 per EA |
|---|---|
| All-time high | $0.0866 (Feb 12, 2014) |
| All-time low | $0.0446 (Jan 18, 2023) |
| Median price | $0.0618 |
| Average price | $0.0616 |
| Largest weekly change | +17.6% (Dec 23, 2015) |
| Weeks tracked | 551 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-16.6%
5Y
-22.3%
All
-42.2%
Last surveyed Jun 12, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Amneal Pharmaceuticals LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Spironolactone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Aldosterone Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SPIRONOLACTONE 25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SPIRONOLACTONE 25 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.0452 per EA (NDC 65162051111), effective Jun 12, 2024.
How has the price of SPIRONOLACTONE 25 MG TABLET changed over time?
Over the history we have for it, the NADAC for SPIRONOLACTONE 25 MG TABLET has declined 42.2%. It has been tracked across 551 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for SPIRONOLACTONE 25 MG TABLET?
Since Nov 28, 2013, the NADAC for SPIRONOLACTONE 25 MG TABLET has ranged from a low of $0.0446 (Jan 18, 2023) to a high of $0.0866 (Feb 12, 2014), with a median of $0.0618 per EA.
Are there cheaper alternatives to SPIRONOLACTONE 25 MG TABLET?
Yes. 5 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, SPIRONOLACTONE 25 MG TABLET, is $0.0426 per EA — about 6% below SPIRONOLACTONE 25 MG TABLET.
Who manufactures SPIRONOLACTONE 25 MG TABLET?
SPIRONOLACTONE 25 MG TABLET (NDC 65162051111) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.